UPDATE: Stifel Nicolaus Raises PT to $35 on Team Health Holdings on EPS Visibility
Stifel Nicolaus reiterated its Buy rating on Team Health Holdings (NYSE: TMH) and the price target from $30.00 to $35.00.
Stifel Nicolaus said, "The flu epidemic has made this the most active flu season in the U.S. since the H1N1 pandemic in the fall of 2009. Our analysis of (admittedly limited) historical data indicates a strong correlation between year-over-year changes in flu activity and Team's same-store volumes. This suggests upside to at least fourth quarter 2012 earnings. Given a favorable operating and acquisition environment, and the positive impact of Medicaid Parity on 2013 and 2014 earnings, we are raising our target price from $30 to $35."
Team Health Holdings closed at $31.89 on Friday.
Latest Ratings for TMH
|Apr 2015||Leerink Swann||Initiates Coverage on||Outperform|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.